|
|
||||||||||||||
|
|
|||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Short reports |
Department of Paediatrics, Addenbrookes Hospital, University of Cambridge, Cambridge, UK
Correspondence to:
Dr C L Acerini, Department of Paediatrics, Addenbrookes Hospital, Hills Road, Cambridge CB2 2QQ, UK; cla22{at}cam.ac.uk
Concordance with growth hormone (GH) therapy in 75 children was objectively assessed using data on GP prescriptions over 12 months. 23% missed >2 injections/week. Lower concordance was associated with longer duration on GH therapy (p<0.005), lack of choice of delivery device (p<0.005) and short prescription durations (p<0.005), and predicted lower height velocities (p<0.05).
Relevant Article
This article has been cited by other articles:
![]() |
Petrou and McIntosh Measuring the benefits of growth hormone therapy in children: a role for preference-based approaches? Arch. Dis. Child., February 1, 2008; 93(2): 95 - 97. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
| ARCH DIS CHILD | FETAL NEONATAL ED | ED PRACTICE |